Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
OTC drugs
Pharma
FDA wants to end sale of oral phenylephrine as OTC decongestant
The FDA has proposed to ban the sale of oral meds containing phenylephrine, an ingredient in many OTC decongestants.
Kevin Dunleavy
Nov 8, 2024 10:32am
Viatris to haul in $3.37B with 3 business divestures
Oct 2, 2023 4:49pm
FDA panel votes to end OTC use of common decongestant drug
Sep 13, 2023 11:00am
Formulated Solutions in deal to buy former Merck, Bayer facility
Dec 20, 2022 9:30am
OTC birth control pill delayed as FDA postpones hearing
Oct 26, 2022 10:05am
Viatris weighs $3B sale of European OTC drugs: Bloomberg
Oct 11, 2022 10:50am
